Ameriprise’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-3,263
| Closed | -$87.3K | – | 3972 |
|
|
2023
Q4 | $87.3K | Sell |
3,263
-851
| -21% | -$22.8K | ﹤0.01% | 3823 |
|
|
2023
Q3 | $249K | Hold |
4,114
| – | – | ﹤0.01% | 3636 |
|
|
2023
Q2 | $419K | Sell |
4,114
-2,669
| -39% | -$272K | ﹤0.01% | 3498 |
|
|
2023
Q1 | $1.2M | Sell |
6,783
-236
| -3% | -$41.7K | ﹤0.01% | 3073 |
|
|
2022
Q4 | $2.72M | Buy |
7,019
+1,833
| +35% | +$709K | ﹤0.01% | 2668 |
|
|
2022
Q3 | $1.75M | Buy |
5,186
+185
| +4% | +$62.3K | ﹤0.01% | 2842 |
|
|
2022
Q2 | $1.64M | Sell |
5,001
-26
| -0.5% | -$8.55K | ﹤0.01% | 2887 |
|
|
2022
Q1 | $2.2M | Sell |
5,027
-301
| -6% | -$132K | ﹤0.01% | 2866 |
|
|
2021
Q4 | $2.34M | Buy |
5,328
+305
| +6% | +$134K | ﹤0.01% | 2885 |
|
|
2021
Q3 | $2.79M | Sell |
5,023
-321
| -6% | -$179K | ﹤0.01% | 2726 |
|
|
2021
Q2 | $2.75M | Buy |
+5,344
| New | +$2.75M | ﹤0.01% | 2779 |
|
|
2018
Q4 | – | Sell |
-2,365
| Closed | -$2.04M | – | 3772 |
|
|
2018
Q3 | $2.04M | Buy |
+2,365
| New | +$2.04M | ﹤0.01% | 2810 |
|
|
2017
Q3 | – | Sell |
-2,231
| Closed | -$1.24M | – | 3754 |
|
|
2017
Q2 | $1.24M | Sell |
2,231
-19
| -0.8% | -$10.5K | ﹤0.01% | 2844 |
|
|
2017
Q1 | $1.49M | Sell |
2,250
-648
| -22% | -$429K | ﹤0.01% | 2708 |
|
|
2016
Q4 | $969K | Buy |
+2,898
| New | +$969K | ﹤0.01% | 2983 |
|
|
2015
Q4 | – | Sell |
-810
| Closed | -$417K | – | 3907 |
|
|
2015
Q3 | $417K | Buy |
+810
| New | +$417K | ﹤0.01% | 3319 |
|